Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 1999

View Archived Issues

Synthetic Blood, Nitric Oxide Solutions team up for development of NO delivery technology

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

SangStat and Abbott sign collaborative agreement for SangCya

FDA clears phase III trial of Cerus's FFP pathogen inactivation system

Phase I trial of Biojector 2000 to deliver malaria DNA vaccine

Risperidone may reduce risk of relapse in schizophrenia

MediGene discovers target gene for DCM therapy

Ligand: Q1 1999 highlights

Betathine trial progressing well

Celltech: interim report October 1998-March 1999

OSI and Pfizer enter license agreement to develop psoriasis treatment

Vivus signs registration and marketing agreement in Japan for Muse

Compounds for promoting hair growth or regrowth disclosed by Shiseido

Early studies indicate efficacy of thalidomide in Crohn's disease

Compounds in development at Shionogi reverse oncogene-induced cell transformation

Calcium channel antagonists from Ajinomoto especially useful in IBS

Yoshitomi reports potent and selective tryptase inhibitors with oral activity

News from DDW: rhIL-10 in treatment of Crohn's disease

The NO-coupled NSAID HCT-1026 does not cause duodenal injury in rat model

Phogen receives further funding from Cantab and Marie Curie Cancer Care for VP22 technology

Cholera vaccine CVD103HgR-pDA60 is an excellent candidate for human studies

Isolex cell selection system receives approval from Health Canada

MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid

FDA advisory panel review of Levulan to be rescheduled

Tibetan herbal compound is effective in treating symptoms of IBS

Xenova: Q1 1999 highlights

Merck researchers describe L-783281, a novel antidiabetic agent of fungal origin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...